4-Chloro-2-(methylthio)-5,6,7,8-tetrahydroquinazoline

CAS : 51660-11-8

Ref. 3D-FC141314

Informations sur le produit

• Nom: 4-Chloro-2-(methylthio)-5,6,7,8-tetrahydroquinazoline
• Synonymes: 4-Chloro-5,6,7,8-tetrahydro-2-(methylthio)quinazoline, Quinazoline, 4-chloro-5,6,7,8-tetrahydro-2-(methylthio)-

Description

Covid-19 is a drug that was developed to combat the H1N1 influenza pandemic. Covid-19 is an N-heterocyclic compound with a monoclinic crystal structure, which can be accessed by resonance parameters and has been studied using nuclear magnetic resonance (NMR) spectroscopy. Covid-19 has shown antiviral properties in vitro. Covid-19 has also been shown to have high affinity for the H1N1 virus and low cytotoxicity to human cells. Covid-19's activity against the H1N1 virus is likely due to its ability to inhibit viral replication.

• Marque: Biosynth

Propriétés chimiques

• Masse moléculaire: 214.72 g/mol
• Formule: C₉H₁₁ClN₂S
• Degré de pureté: Min. 95%
• InChI: InChI=1S/C9H11ClN2S/c1-13-9-11-7-5-3-2-4-6(7)8(10)12-9/h2-5H2,1H3
• Code InChI: InChIKey=XDQBZDZLOKZGBN-UHFFFAOYSA-N
• SMILES: CSc1nc(Cl)c2c(n1)CCCC2